arrow_right
PROVIDING ANSWERS AT EVERY STEP OF THE LUNG CANCER PATIENT JOURNEY
arrow icon
arrow icon
LUNG NODULE DETECTED
DIAGNOSTIC BRONCHOSCOPY
CONFIRMED MALIGNANCY
LUNG NODULE DETECTED
PERCEPTA
NASAL SWAB
DIAGNOSTIC BRONCHOSCOPY
PERCEPTA
GENOMIC SEQUENCING CLASSIFIER
CONFIRMED MALIGNANCY
PERCEPTA
GENOMIC ATLAS
See how we’re
disrupting the
lung cancer care
continuum
with novel genomic tests
Michael Bernstein, MD
Co-clinical Director for the Lung Cancer Screening and Lung Nodule Program, Stamford Hospital
Gaps in the Lung Cancer Diagnosis and Care Continuum
Michael Bernstein, MD, discusses the unmet need in lung cancer diagnosis and care continuum.
Bill Bulman, MD
Medical Director, Lung Cancer, Veracyte
Veracyte’s Vision and Portfolio for Transforming Lung Cancer Care
Bill Bulman, MD, discusses the transformative role of novel genomic tests, such as a noninvasive nasal swab for early lung cancer detection and a comprehensive genomic profiling test for more informed treatment decision making.
Chakravarthy Reddy, MD
Associate Professor, University of Utah School of Medicine
Percepta GSC Overview and Integration in Clinical Practice
Hear Chakravarthy Reddy, MD, share an overview of the Percepta Genomic Sequencing Classifier to stratify the risk of lung cancer when bronchoscopy is inconclusive and how to integrate this test into clinical practice.
Sign up and be among the first to offer these tests in your practice
Specialty*
Which Tests Interest You?*
CONTACT REP
© 2021 Veracyte, Inc. All rights reserved.